TORONTO, March 06, 2018 -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Trial Supply New England 2018, March 7-8 in Boston.
“We are excited to participate in events focused on Clinical Trial Supply. At the core of Axiom Fusion, our eClinical suite, are the IWRS/IxRS and Inventory Management Modules,” expressed Andrew Schachter, CEO and Founder.
Heather Di Fruscia, Axiom’s IWRS expert enthusiastically contributed, “With Fusion’s flexibility and my team’s expertise and IxRS consulting, we work with our clients to choose the right amount of control over subject eligibility and when and how much inventory should be on hand.
Fusion’s capacity for automated predictive resupply allows our clients and their preferred vendors to focus on other important study details instead of worrying about sufficient inventory for upcoming subject visits.
Overall, our strategic, customized approach to planning, design and implementation ensures that our clients and their inventory are well taken care of.”
Andrew Schachter concluded, “Our established ROI and our delivery on these modules and services positions us as both cost efficient and best-in-class. We invite attendees to come and visit us at Booth 12 for a conversation and demo over coffee.”
About Axiom Real-Time Metrics
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.
CONTACT INFORMATION
Contact
[email protected]
+1.877.321.9191
PR Contact
Sarah Glofcheskie
[email protected]
+1.647.588.9073


Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
OpenAI Restricts Astra AI Over Cyberattack Risks
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 



